Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 41-49 of 49 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2013Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney diseaseDe Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H.; McMurray, J.; Meyer, C.; Parving, H.; Remuzzi, G.; Toto, R.; Vaziri, N.; Wanner, C.; Wittes, J.; Wrolstad, D.; Chertow, G.; et al.
2017Developing a set of core outcomes for trials in hemodialysis: an international Delphi surveyEvangelidis, N.; Tong, A.; Manns, B.; Hemmelgarn, B.; Wheeler, D.C.; Tugwell, P.; Crowe, S.; Harris, T.; Van Biesen, W.; Winkelmayer, W.C.; Sautenet, B.; O'Donoghue, D.; Tam-Tham, H.; Youssouf, S.; Mandayam, S.; Ju, A.; Hawley, C.; Pollock, C.; Harris, D.C.; Johnson, D.W.; et al.
2012Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010Salomon, J.A.; Vos, T.; Hogan, D.R.; Gagnon, M.; Naghavi, M.; Mokdad, A.; Begum, N.; Shah, R.; Karyana, M.; Kosen, S.; Farje, M.R.; Moncada, G.; Dutta, A.; Sazawal, S.; Dyer, A.; Seiler, J.; Aboyans, V.; Baker, L.; Baxter, A.; Benjamin, E.J.; et al.
2017Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trialRutten, M.; Van Meurs, H.; Van De Vrie, R.; Gaarenstroom, K.; Naaktgeboren, C.; Van Gorp, T.; Brugge, H.; Hofhuis, W.; Schreuder, H.; Arts, H.; Zusterzeel, P.; Pijnenborg, J.; Van Haaften, M.; Fons, G.; Engelen, M.; Boss, E.; Vos, M.; Gerestein, K.; Schutter, E.; Opmeer, B.; et al.
2017Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisHerold, T.; Schneider, S.; Metzeler, K.; Neumann, M.; Hartmann, L.; Roberts, K.; Konstandin, N.; Greif, P.; Braeundl, K.; Ksienzyk, B.; Huk, N.; Schneider, I.; Zellmeier, E.; Jurinovic, V.; Mansmann, U.; Hiddemann, W.; Mullighan, C.; Bohlander, S.; Spiekermann, K.; Hoelzer, D.; et al.
2013SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerFleming, N.; Jorissen, R.; Mouradov, D.; Christie, M.; Sakthianandeswaren, A.; Palmieri, M.; Day, F.; Li, S.; Tsui, C.; Lipton, L.; Desai, J.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; Zhu, H.; Mariadason, J.; Burgess, A.; et al.
2015Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trialCADISS trial investigators,; Markus, H.; Hayter, E.; Levi, C.; Feldman, A.; Venables, G.; Norris, J.; Peycke, J.; Willson, M.; Hicks, C.; Hayter, E.; Madigan, J.; Clifton, A.; Menon, R.; Kennedy, F.; Khan, U.; Feldman, A.; Hollocks, M.; Markus, H.; King, A.; et al.
2011Progesterone receptor gene variants and risk of endometrial cancerO'Mara, T.; Fahey, P.; Ferguson, K.; Marquart, L.; Lambrechts, D.; Despierre, E.; Vergote, I.; Amant, F.; Hall, P.; Liu, J.; Czene, K.; SASBAC,; Rebbeck, T.; WISE Study Group,; AOCS Management Group,; SEARCH,; Ahmed, S.; Dunning, A.; Gregory, C.; Shah, M.; et al.